Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Cephalon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA (bendamustine hydrochloride) for Injection for the treatment of patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow disease, on March 20, 2008.

7 Apr 2008

Aripiprazole has potential for treating alcohol dependence

Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.

4 Apr 2008

Oligosaccharides may help fight Salmonella and other food poisoning bacteria

Natural sugars found in breast milk that are now included in prebiotic foods may help in the fight against Salmonella and other food poisoning bacteria, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

2 Apr 2008

HIV-positive women in the United States face strikingly high levels of stigma

HIV-positive women in the United States face strikingly high levels of stigma, according to survey results released today by amfAR, The Foundation for AIDS Research.

1 Apr 2008

Naglazyme approved in Japan

BioMarin Pharmaceutical Inc. has announced that AnGes MG, Inc. (AnGes), BioMarin's marketing and distribution partner in Japan, has received approval for its Marketing Application for Naglazyme(R) (galsulfase) from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with Mucopolysaccharidosis VI ( MPS VI).

1 Apr 2008

FDA issues Salmonella Litchfield alert for cantaloupe from Agropecuaria Montelibano

The U.S. Food and Drug Administration has issued an import alert regarding entry of cantaloupe from Agropecuaria Montelibano, a Honduran grower and packer, because, based on current information, fruit from this company appears to be associated with a Salmonella Litchfield outbreak in the United States and Canada.

28 Mar 2008

Experts warn, no Easter chocolate for pets!

Experts are warning pet owners not to give their dogs or cats chocolate over the Easter period.

19 Mar 2008

Cocaine can cause symptoms of a heart attack

According to new research from the U.S., using cocaine can cause chest pain and other symptoms similar to a heart attack.

19 Mar 2008

Dengue fever warnings for WA and far north Queensland

The Health Department in West Australia say there is a sharp increase in the mosquito-borne viral infection Dengue fever in people returning from Indonesia.

19 Mar 2008

NanoBio successfully completes phase 2b study in Herpes labialis

NanoBio Corporation reported top-level findings from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores).

18 Mar 2008

Breast cancer more aggressive among overweight or obese women

Women with breast cancer have more aggressive disease and lower survival rates if they are overweight or obese, according to findings published in the March 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

17 Mar 2008

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

11 Mar 2008

Alcohol may increase blood pressure to a much greater extent than previously thought

Previous observational studies have reported that heavy alcohol intake is a risk factor for hypertension but such studies may be confounded by factors such as diet, smoking, exercise levels and socio-economic position.

6 Mar 2008

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Eisai Corporation of North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.

4 Mar 2008

Colon cancer treatment, symptoms, clinical trials

Fewer people are dying from colorectal cancer, but it remains the third deadliest form of cancer in America.

4 Mar 2008

Hypertension linked to heavy drinking

According to British researchers the relationship between heavy drinking and high blood pressure is more significant than previously thought.

4 Mar 2008

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) has approved PRISTIQ (desvenlafaxine), a structurally novel, once-daily serotonin-norepinephrine reuptake inhibitor (SNRI), to treat adult patients with major depressive disorder (MDD).

3 Mar 2008

Abilify (aripiprazole) approved for acute treatment of bipolar I disorder in adolescents

Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).

1 Mar 2008

FDA approves Nexium for gastroesophageal reflux disease in children

The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD).

28 Feb 2008

OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer

Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy.

27 Feb 2008

Nausea News and Research

Further Reading

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

Aripiprazole has potential for treating alcohol dependence

Oligosaccharides may help fight Salmonella and other food poisoning bacteria

HIV-positive women in the United States face strikingly high levels of stigma

Naglazyme approved in Japan

FDA issues Salmonella Litchfield alert for cantaloupe from Agropecuaria Montelibano

Experts warn, no Easter chocolate for pets!

Cocaine can cause symptoms of a heart attack

Dengue fever warnings for WA and far north Queensland

NanoBio successfully completes phase 2b study in Herpes labialis

Breast cancer more aggressive among overweight or obese women

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Alcohol may increase blood pressure to a much greater extent than previously thought

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Colon cancer treatment, symptoms, clinical trials

Hypertension linked to heavy drinking

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

Abilify (aripiprazole) approved for acute treatment of bipolar I disorder in adolescents

FDA approves Nexium for gastroesophageal reflux disease in children

OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News